Canadian Liver Foundation Announces New Chair of the Board of Directors
I am pleased to announced Elliott Jacobson as our new Chair of the Canadian Liver Foundation Board of Directors effective January 1, 2021. This position has previously been held by Dr. Morris Sherman since 2009.
Dr. Morris Sherman first joined us in 2004, and was appointed as Chair of the Medical Advisory Committee in 2006. He took over as Chair in 2009. A now retired hepatologist, Dr. Sherman has been a leader in the field of studying the liver and advancing liver disease treatment and care in Canada and has been a tireless advocate for patients and access to treatment for over 30 years. As an expert in the field, he has been a powerful voice speaking out on liver issues, and one we are proud and lucky to have the support of as an organization.
Elliott Jacobson has been a long-standing member of our team, sitting on the Board of Directors as Treasurer from 1999 to 2006, then returning in 2010 as Finance and Audit Committee Co-Chair. In 2011, he stepped back into the role of Treasurer, and took over as Chair of the Finance and Audit Committee, holding this position since.
With over 30 years of public accounting experience, Elliott has spent his career as an expert on auditing and accounting for public companies. He has established himself as a leader in his sector providing counsel and leading services for companies on their initial public offerings, public company audits, and navigating issues with internal and external audiences. Bringing this professional background and expertise to the Canadian Liver Foundation Board of Directors, he brings a meaningful professional perspective to the work we do and has supported our efforts in ensuring we are effectively delivering on our mission of bringing research to life.
As Dr. Sherman begins his retirement, he is happy to transfer this role to Elliott and confident in his ability to lead our Board of Directors. Having worked with both Dr. Sherman and Elliott over this last year, I share this confidence and am looking forward to the work ahead.
I want to extend my deepest gratitude and appreciation for the dedication and work of Dr. Sherman over the last 11 years. It is thanks to leaders like him that we have been able to continuously provide support to our community and progress liver disease research and care, and for that the entire team at the Canadian Liver Foundation is thankful.
Looking ahead to 2021, I am excited to work with Elliott and the Board of Directors as we continue our work towards creating a world without liver disease. Please join me in wishing Dr. Sherman a wonderful retirement, and congratulating Elliott on the start of this new exciting role.
President and CEO
Canadian Liver Foundation